Tumor necrosis factor-α-mediated severity of idiopathic retinal periphlebitis in young adults (Eales’ disease): implication for anti-TNF-α therapy
Tóm tắt
Tumor necrosis factor-alpha (TNF-α) is a pleiotropic inflammatory cytokine. Tumor necrosis factor-alpha was evaluated in the serum samples of patients with idiopathic retinal periphlebitis in young adults (Eales’ disease). Retinal periphlebitis was graded according to a new grading system based on severity of inflammation (grade 1–4). Quantification of the TNF-α levels was carried out using ELISA kit in the serum samples of young adults with idiopathic retinal periphlebitis (n = 17) and healthy controls (n = 17) of similar age. Tumor necrosis factor-α level was found to be significantly raised in cases with retinal periphlebitis as compared with controls (p < 0.001). Higher levels of TNF-α were found to be associated with increased severity of retinal periphlebitis. Tumor necrosis factor-α represents a novel target for controlling inflammatory activity in idiopathic retinal periphlebitis. Higher levels of TNF-α, in association with the increased severity of retinal periphlebitis, have implications for early anti-TNF-α therapy.
Tài liệu tham khảo
Gieser SC, Murphy RP. Eales' disease. In: Ryan SJ, editor. Retina Vol II. Medical retina. St. Louis: CV Mosby; 1994.
Atmaca LS, Idil A, Gunduz K. Visualization of retinal vasculitis in Eales disease. Ocul Immunol Inflamm. 1993;1:41–8.
Bali T, Saxena S, Kumar D, Nath R. Response time and efficacy of oral methotrexate pulsed therapy in idiopathic retinal periphlebitis. Eur J Ophthalmol. 2005;15:374–8.
Saxena S, Rajasingh J, Biswas S, Kumar D, Shinohara T, Singh VK. Cellular response to retinal S-antigen and interphotoreceptor retinoid binding protein fragments in patients with Eales' disease. Pathobiology. 1999;67:37–44.
Saxena S, Srivastava P, Kumar D, Khanna VK, Seth PK. Decreased platelet membrane fluidity in retinal periphlebitis in Eales’ disease. Ocul Immunol Inflamm. 2006;14:113–16.
Saxena S, Kumar D. A new staging system for idiopathic retinal periphlebitis. Eur J Ophthalmol. 2004;14:236–9.
Inomata H, Ishibashi T, Murata T, Iwasaki M, Tahara A, Hata K, et al. Intraocular neovascularization. Nippon Ganka Gakkai Zasshi. 1997;101:906–26.
Kawashima M, Shoji J, Kamura Y, Sato Y. Role of chemokines in the vitreous of proliferative diabetic retinopathy. Nippon Ganka Gakkai Zasshi. 2005;109:596–602.
Rai G, Saxena S, Kumar H, Singh VK. Human retinal S-antigen: T cell epitope mapping in posterior uveitis patients. Exp Mol Pathol. 2001;70:140–5.
Tripathi P, Saxena S, Yadav VS, Naik S, Singh VK. Human S-antigen: peptide determinant recognition in uveitis patients. Exp Mol Pathol. 2004;76:122–8.
Armstrong D, Ueda T, Ueda T, et al. Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis. 1998;2:93–104.
Dinarello CA. Proinflammatory cytokines. Chest. 2000;118:503–8.
Saxena S, Pant AB, Khanna VK, Singh K, Kumar D, Singh VK. Interleukin-1 and tumor necrosis factor-alpha: novel targets for immunotherapy in Eales’ disease. Ocul Immunol Inflamm. 2009;17:201–6.
Kriegler M, Perez C, DeFay K, Albert I, Lu SD. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell. 1988;53:45–53.
Tang P, Hung MC, Klostergaard J. Human pro-tumor necrosis factor is a homotrimer. Biochemistry. 1996;35:8216–25.
Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997;385:729–33.
Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104:487–501.
Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10:45–65.
Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science. 2002;296:1634–5.
Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol. 2003;66:1403–8.
Hunter CA, Timans J, Pisacane P, Menon S, Cai G, Walker W, et al. Comparison of the effects of interleukin-1 alpha interleukin-1 beta and interferon-gamma inducing factor on the production of interferon-gamma by natural killer. Eur J Immunol. 1997;27:2787–92.
Theodossiadis PG, Markomichelakis NN, Sfikakis PP. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. Retina. 2007;27:399–413.
Le Thi HD, Cassoux N, Lebrun-Vignes B, Wechsler B, Bodaghi B, Lehoang P, et al. Therapy of chronic non infectious uveitis. Rev Med Intern. 2007;28:232–41.